Author

Alicia Catezone

Northwestern University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Adam M. SonabendiD· 1 shared Atique U. AhmediD· 1 shared Ayaan Akhtar· 1 shared Brenda Auffinger· 1 shared Dieter Henrik HeilandiD· 1 shared Ditte PrimdahliD· 1 shared Hasaan A Kazi· 1 shared Jason M. MiskaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam M. SonabendORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Temozolomide-associated inflammatory-repair remodeling in recurrent glioblastoma exposes a ROCK-linked therapeutic vulnerability

Rafał Chojak, Umme Habiba Faisal, Priya Kumthekar, Noah B. Drewes, Lara Koutah, Jessica Jia, Jillyn R Turunen, Maeve C. O’Shea, Victoria Falkowski, Ayaan Akhtar, Shu Wang, Justin Chen, Shanti Ahmed, Hasaan A Kazi, Brenda Auffinger, , Atique U. Ahmed

This study shows that preoperative temozolomide exposure in recurrent glioblastoma leads to inflammatory-repair remodeling and a ROCK-linked therapeutic vulnerability, which can be targeted by fasudil.

bioRxiv · Sep 22, 2026 · PreprintCancer Biology